Deciphering how complex, circuit-wide neural signaling in the central nervous system (CNS) and peripheral nervous system (PNS) governs higher-order cognitive functions is a primary goal in neuroscience research. The gut-brain interface exemplifies one such frontier. Recent reports have shown that signaling from the gut affects appetitive decisions and has profound implications on emotions and social interactions. However, the neural bases and mechanisms underlying such brain-viscera communication networks remain elusive. One obstacle to understanding these mechanisms is the lack of versatile technologies that can stably interface with diverse anatomical regions, while being scalable, customizable, and capable of bidirectional recording and stimulation over chronic time scales.
Multifunctional microelectronics fiber probes, also called microelectronics-integrated multifunctional fiber probes or multifunctional fiber probes, can stimulate and monitor neural signaling between the brain and the gut or in other tubular organ systems, such as blood vessels or reproductive organs. Multifunctional fiber probes implanted in the brain can also be referred to as brain fiber probes, and multifunctional fiber probes implanted in the gut or gastrointestinal tract (GI) can be referred to as gut fiber probes or GI fiber probes. An example multifunctional fiber probe includes a polymer fiber segment having (i) a proximal end and (ii) a distal end configured to be inserted into tissue. One or more microfluidic channels run along a length of the polymer fiber segment. Each channel has a first opening toward the proximal end of the polymer fiber segment and a second opening toward the distal end of the polymer fiber segment and may have other openings at either end and/or along the length of the polymer fiber segment. Openings at the tip are useful for brain fiber probes, and openings partway along the length are useful for gut or GI fiber probes.
In operation, these microfluidic channels can convey fluid from the first opening to the second opening and vice versa. Flowing fluid from the proximal end to the distal end is useful for injecting nutrients in gut fiber probes. Sucking fluid into the distal end is useful for injecting a virus payload in the brain: the viral payload is sucked up into the microfluidic channel first (also called front loading of the channel) and then pushed out of the the microfluidic channel and into a targeted site in the brain or other tissue. Other implanted fibers cannot suck up biological fluids.
The multifunctional fiber probe also includes electrodes and electrical interconnects running along the length of the polymer fiber segment, solid-state devices disposed along a distal portion of the polymer fiber segment in electrical communication with the electrical interconnects, and a control module at a proximal end of the polymer fiber segment and connected to the electrical interconnects and the electrodes. The electrodes are configured to make electrophysiology measurements of the tissue. The electrical interconnects convey data and/or commands between the solid-state devices, which are configured to interact with the tissue, and the control module, which is configured to record the electrophysiology measurements and to control the solid-state devices. The control module may include a wired or wireless transceiver configured to receive commands from an external device and/or to transmit data to the external device.
The polymer fiber segment may include polycarbonate (PC), styrene-ethylene-butylene-styrene (SEBS), cyclic olefin copolymer (COC), cyclic olefin co-polymer Elastomer (ECOC), polymethylmethacrylate (PMMA), polyphenylsulfone (PPSU), polyetherimide (PEI), and/or conducting polyethylene (CPE), depending in part on the fiber probe's implantation site. Polymer fiber segments used for brain implantation may have a Young's modulus of 2.3-3.0 GPa and a bending stiffness (single cantilever mode) of 25-30 N/m, whereas those used for gut implantation may have a Young's modulus of 5-30 MPa and a bending stiffness (single cantilever mode) of 2-5 N/m.
The solid-state devices can include devices with two or three electrical connections, such as (micro) light-emitting diodes (μLEDs, possibly coated with phosphors), temperature sensors, piezoelectric or pressure sensors, photodiodes, Joule heaters, and/or other devices. The μLEDs can be used for photopharmacology (e.g., with ultraviolet or red light), drug delivery (e.g., from hydrogels or other light-responsive delivery systems), and/or optogenetically modulate tissue (e.g., with pulses of green, blue, and/or red light).
A multifunctional fiber probe can be made by forming a polymer preform defining channels, then thermally drawing the polymer preform to form several hundred meters of multifunctional fiber. The multifunctional fiber is cut or segmented into multifunctional fiber probes. For each multifunctional fiber probe, a distal portion of a conductor running through one of the channels is exposed and electrically coupled to one or more solid-state devices.
Some multifunctional fiber probes may have two or more separate multifunctional fiber segments and implanted at different sites. For example, one segment can be implanted in the gut and another segment can be implanted in the brain. Alternatively, two segments can be implanted in different portions of the brain or in different portions of the gut. These segments can be coupled to the same control module, either directly or through a stretchable interconnect in the form of a helically coiled fiber with embedded metal microwires.
A stretchable interconnect (also referred to as a helical fiber or helical interconnect) can be fabricated using the scalable thermal drawing approach. Such a helical fiber has broken axial symmetry and is produced by engineering an in-situ residual strain on the fiber during the drawing process. This is done by choosing an elastomeric core material such as SEBS within a non-elastomeric cladding material such as PMMA. The intrinsically stored strain energy can produce out-of-plane buckling of the elastomeric core, resulting in a flexible, stretchable helical fiber, for a preform composed of materials (such as SEBS and PMMA) with different Young's moduli and having a non-centrosymmetric cross-sectional geometry.
Highly conducting fiber based stretchable interconnects composed of SEBS cladding with converged tungsten microwires (25 μm diameter) can be produced using scalable thermal drawing. The stiff metal microwires embedded in the helical fiber are now also stretchable due to the geometry of the helical fiber; shaping the geometry of the fiber into a helical form induces stretchability in the composed helical fiber (elastomeric polymer with embedded metal microwires). In one implementation of the helical fiber, the helical fiber or stretchable interconnect is connected on one end to a control module and on the other end to a brain fiber probe (multifunctional fiber probe implanted in the brain). In another example, a 4-5 cm long flexible helical fiber connects a gut fiber probe on the distal end to the control module on the proximal end, making up a total fiber probe length of 8-10 cm. The length of the helical fiber connected to the fiber probe can be selected depending on the location and depth of implantation.
All combinations of the foregoing concepts and additional concepts discussed in greater detail below (provided such concepts are not mutually inconsistent) are contemplated as being part of the inventive subject matter disclosed herein. All combinations of claimed subject matter appearing at the end of this disclosure are contemplated as being part of the inventive subject matter disclosed herein. The terminology explicitly employed herein that also may appear in any disclosure incorporated by reference should be accorded a meaning most consistent with the concepts disclosed herein.
The skilled artisan will understand that the drawings primarily are for illustrative purposes and are not intended to limit the scope of the inventive subject matter described herein. The drawings are not necessarily to scale; in some instances, various aspects of the inventive subject matter disclosed herein may be shown exaggerated or enlarged in the drawings to facilitate an understanding of different features. In the drawings, like reference characters generally refer to like features (e.g., functionally similar and/or structurally similar elements).
Here we introduce microelectronics-integrated multifunctional fiber probes that can interface stably with diverse anatomical regions, including the brain and gastrointestinal (GI) tract. Multifunctional fiber probes implanted in the brain can also be referred to as brain fiber probes, and multifunctional fiber probes implanted in the gut or GI can be referred to as gut fiber probes or GI fiber probes. Other multifunctional fiber probes are dual brain-GI fibers probes with two fiber segments, both coupled to the same control module, with one configured to be implanted in the brain and the other configured to be implanted in the gut or GI tract. These multifunctional fiber probes are scalable, customizable, and capable of bidirectional recording and stimulation over chronic time scales.
Our wireless multifunctional fiber probes act as bioelectronic interfaces that are compatible for chronic implantation with diverse organ systems in freely behaving mice. We leverage a single-step, scalable fiber drawing process to produce hundreds of meters of microscale polymer fiber that can integrate solid-state semiconductor chips along their surfaces in a single production run. Coupled together with deterministic tunability of fiber mechanics, this approach offers unprecedented design flexibility which is demonstrated by producing stiff yet flexible multifunctional fiber probes for the brain (brain fiber probes) and soft compliant fiber probes for the gut (gut/GI fiber probes).
We also overcome outstanding challenges associated with thermal drawing process (TDP). For example, thermally drawn devices have tip-localized functionality, use passive components for sensing/actuation, and are incompatible with tether-free operation. By embedding microelectronics in the fiber probes, we break their axial redundancy and unlock new actuation (lateral optical illumination) and sensing modes (thermal sensors), which can be further extended in scope using commercial off-the-shelf components. We show that fiber probe implants can be controlled wirelessly with modules attached to their proximal ends.
This complete platform addresses several limitations of other technologies, including the conventional cleanroom-based microfabrication techniques that are currently used for producing wireless multifunctional neural interfaces. Microfabrication typically involves a series of lithography, etching and transfer printing steps in resource-intensive cleanroom settings. Rapid customization of microfabricated device layouts becomes prohibitive as each pattern requires design of a new photomask and optimization of several physical/chemical steps. Moreover, lithography based thin-film processes also preclude monolithic integration and instead require manual assembly of individually fabricated layers to form a multifunctional device stack. Low fabrication throughput and limitations on device lengths are other associated hurdles, especially for deployment in anatomically hard-to-reach sites in the peripheral nervous system (PNS).
We leverage our technological advances to study and wirelessly modulate gut-brain neural circuits in awake-behaving animals. The multifunctionality in brain fiber probes enables several recording and stimulation experiments in-vivo such as gene delivery, dynamic and chronic optoelectrophysiology, single neuron recording, sensing of brain hypothermia, and wireless programmable optical control of reward behavior. Soft, multifunctional GI fiber probes uniquely enable light and chemical delivery to targeted sites in the intestinal lumen for modulation of gut enteroendocrine cells and vagal afferents. These fiber probes create a generalized strategy for gut lumen optogenetics that can be extended to other cell types (e.g., neuropod cells), the enteric nervous system, and the spinal nerve branch innervating the gut. This is not possible with current fiber optic approaches that target cell bodies in the brain stem.
These advanced fiber probes facilitate understanding of how gut sensory function governs emotional states and cognitive processes in the brain in health and disease. This allows researchers to take advantage of widely available transgenic mouse lines and perform direct peripheral optogenetics along the GI tract that bypasses complex retrograde viral injections. The devices and concepts developed here can be directly extended to multimodal neuromodulation of other hollow, tubular organ systems such as blood vessels and reproductive tissues in awake-behaving mice. The successful independent validation of brain and gut fiber probes creates exciting opportunities for their co-implantation into these organs in the same animal to help understand bi-directional signal transduction in associated neural circuits. Thus, the technology disclosed here enable wireless interrogation of brain-viscera neuronal communication networks across multiple modalities in health and disease.
Soft, compliant multifunctional gut or GI fiber probes can deliver light and chemicals in the gut lumen, allowing direct modulation of different components of GI neural circuitry, such as the epithelial neuropod cells and upper-gut innervating vagal afferents. Fiber probes implanted in the ventral tegmental area (VTA) and coupled to NeuroStack can optogenetically stimulate dopaminergic neurons to elicit classic reward behavior. Furthermore, the GI fiber probes help reveal that optogenetic stimulation of vagal afferents from the gut lumen also produces a rewarding phenotype, thereby demonstrating for the first-time direct modulation of central nervous system function from the intestine in awake-behaving mice. These applications can be used in systems neuroscience for understanding brain-viscera neural communication networks.
A microelectronics-integrated multifunctional fiber probe for the brain (brain fiber probe) 200 can be made by thermally drawing a multilayer polycarbonate (PC) preform (PC, Tg=160° C., E=1.8-3.2 GPa), whose layout 201a is shown in
The overall cross-sectional geometry of the preform 201b, with interconnect channel 211, electrode channel 221, and microfluidic channel 231, shown in
Incorporation of tungsten microwires in fiber probes afforded low impedance microelectrodes (|Z| of 46.3±6 kΩ at 1 kHz) for in-vivo electrophysiology while still retaining fiber flexibility (
We used finite element modelling (FEM) to investigate how optical intensity, illumination depth, and volume varied with distance from the μLED at varying input intensities. From this analysis it is apparent that even a moderate illumination intensity of 30 mW/mm2 covers a tissue volume of ˜0.75 mm3 around the fiber probe tip, sufficient for optogenetics in most brain nuclei.
We leveraged the temperature-dependent I-V characteristics of the μLED (InGaN μLED, λ=470 nm) to operate it as a microscale thermal sensor for recording heat dissipation in the tissue during μLED operation. A linear dependence of diode current on temperature defined the sensor calibration curve (
Unlike the brain, the gut generally prevents chronic implantation of rigid devices owing to a tortuous, tubular anatomy involving delicate tissue that encases a lumen through which ingested food and fluids pass. Hence, multifunctional fiber probes for the gut (gut fiber probes) are more compliant (e.g., 10-15 times less stiff) than the fiber probes for the brain (brain fiber probes). They also have μLEDs and microfluidic channels that enable site-specific delivery of light and nutrients, respectively, in the intestinal lumen of awake-behaving mice.
For optical characterization of GI fiber probes, we first measured the cumulative light output from the three axially distributed μLEDs and their functional stability in PBS over several weeks. The surface-mounted μLEDs also enable a laterally directed illumination profile for the GI fiber probes. This illumination profile allows spatial targeting of gut epithelial cells and vagal afferents from within the lumen, in contrast to a mismatched dorsal-ventral oriented light cone of silica waveguide. We measured the total optical output on the outer surface of the intestinal wall and observed only modest attenuation in optical power in the presence of the tissue. Using FEM simulations, the optical penetration depth in the gut wall was found to be between 1.65 to 2.5 mm, and the total illumination volume was estimated to be between 0.9-8.8 mm3. This is sufficient to broadly cover the subepithelial mucosa layer that receives dense vagal innervation and is situated within 50-100 μm from mucosal membrane. For a range of illumination intensities, the temperature change in the gut wall was negligible, while the μLED separation was sufficient at about 1 mm to prevent co-operative heat buildup. These combined modelling and experimental studies provide quantitative insights into the illumination and thermal characteristics of GI fiber probes for gut optogenetics.
Since surgical implantation of the GI fiber probe involves bending the fiber portion of the fiber probe at acute radii, we simulated strain distribution in the copper interconnects. The copper interconnects have the lowest yield strain among the fiber probe constituents, which was below the elastic limit of 0.3% for radii>0.5 cm, as shown in
Simultaneous multi-organ (for example, gut-brain) implantation of multifunctional fiber probes can motivate future functional studies of interoceptive neural circuits with these or similar multi-site wireless devices. Such a device can include both gut and brain implantable fiber probes connected to a common wireless module via the same I/O interface. Unfortunately, attaching both the brain and gut fiber probes directly to the same I/O interface can restrict the fiber probes' free motion in three-dimensional space. This, in turn, can prevent accurate positioning of the fiber probe over a brain region of interest, which is helpful for precise targeting in rodent brain surgeries.
To address these challenges, we use a stretchable interconnect in the form of a helically coiled fiber (also called a stretchable interconnect, helical fiber, or helical interconnect) with embedded metal microwires using the scalable thermal drawing approach. Such a non-conventional helical fiber with broken axial symmetry can be produced by engineering an in-situ strain during the drawing process by appropriate choice of elastomeric core and non-elastomeric cladding materials. Accumulation of residual strain in the elastomeric core when it is drawn within a non-elastomeric cladding material, potentially originating from differences in melt viscosities at the drawing temperature, can produce out-of-plane buckling of the elastomeric core if it is composed of materials with differing Young's moduli and has a non-centrosymmetric cross-sectional geometry.
With this fabrication process, we produced highly conducting stretchable interconnects/helical fibers composed of SEBS cladding with converged/embedded tungsten microwires (25 μm diameter). Stretchability is induced in these helical fibers due to the manipulation of their geometry into the helically coiled shape. Even if included in a soft GI fiber probe made of soft SEBS polymer, the embedded metal microwires would still have limited stretchability. Conversely, the same stiff metal microwires, when embedded in a pre-strained SEBS fiber that is released from a PMMA outer cladding, assume the same helical shape as the SEBS fiber. When the helical SEBS fiber is then stretched, its embedded metal microwires also stretch, resulting in more freedom of motion and allowing both brain and GI fiber probes to be implanted and connected to the same I/O interface.
In another implementation, 4-5 cm of the 8-10 cm length of implanted gut fiber probe can be helical fiber to allow for more flexibility in motion. Helical fiber can form part of the brain fiber probe, the GI fiber probe, or both, and the total length of the helical fiber to be used can be adjusted depending on the location and depth of implantation. The form 400′ of helical fiber 400, in the inset of the right side of
NeuroStack enables programmable and bidirectional wireless control of microelectronics-integrated multifunctional fiber probes.
Incorporation of microelectronics in polymer fiber probes provides a unique opportunity for bi-directional wireless operation in the context of animal behavior experiments. To realize this, we designed and assembled NeuroStack 500, which enables programmable wireless optical stimulation across two independent channels and data transfer for temperature recording.
We characterized the system capabilities of NeuroStack in terms of controlling the frequency, duty cycle, pulse shape, and the intensity of the optical stimulation in real-time from a user-friendly graphical user interface (GUI). The creation of the stimulation pulse includes two phases controlled by software timers. One of the timers manages the change in state between pulsing and resting period, thereby controlling frequency of optical stimulation (
The thin, flexible fiber probes may show reduced relative micromotion in the brain tissue and can enable stable recording of single neuron activity over extended periods, which is relevant for many neurobiological studies. After confirming the functional stability of implanted electrodes over several weeks, we successfully recorded spontaneous neural activity from putative VTA neurons in chronically implanted mice (
The biocompatibility of brain fiber probes was confirmed by immunohistochemical analysis of markers characteristic of glial scarring (activated macrophage marker ionized calcium-binding adaptor molecule 1 (Iba1), astrocytic marker glial fibrillary acidic protein (GFAP)). The immune response from polymer fiber probes was compared to that from a silica waveguide of comparable size (300 μm) at week-2 (P<0.05 for Iba1, P<0.001 for GFAP) and week-6 (P<0.05 for GFAP) post-implantation. We observed a consistently lower tissue response for polymer fiber probes at both the time points across all glial markers, which agrees with the reduced tissue micromotion predicted from FEM as well as lower bending stiffness observed experimentally.
While techniques like optogenetics and pharmacology have revolutionized understanding of the brain, extending these methodologies to multimodal interrogation of gut neural circuits has remained out of reach. Our soft multifunctional GI fiber probes are capable of targeted light and chemical delivery along the GI tract and can address this challenge.
Neuropod cells are intestinal sensory epithelial cells that synapse with the vagal afferents and transduce signals to the brain-stem via the vagus nerve within milliseconds. We used this paradigm as a testbed to evaluate the dual opto-fluidic modality of fiber probes using cervical vagus nerve electrophysiology as a readout (
Neuropod cells are expressed along the entire alimentary tract, where they release hormones and neurotransmitters to regulate food intake. To evaluate the impact of neuropod cells in feeding, we implanted the soft GI fiber probe in two distinct gastrointestinal regions: the duodenum and the ileum. The proper function of the intestinal lumen is critical for survival, so we first evaluated whether chronic implantation of the multifunctional fiber probes in the gut (
The soft GI fiber probe was implanted in the duodenum of Cck::ChR2 mice (n=4). A schematic illustration depicting optogenetic control of duodenal Cck+ cells with implanted gut fiber in the duodenum is shown in
We then aimed to modulate food intake from a distinct GI region. In the ileum, the presence of fat and carbohydrates induces a process termed the ileal brake, caused by the release of the gut neuropeptides peptide YY (PYY) and glucagon-like peptide 1. The result is slowed gastric emptying, inhibited intestinal transit, and satiety. We reasoned that opotogenetic stimulation of neuropod cells in the ileum, genetically marked by Pyy, could stimulate the ileal brake, measured by a suppression of food intake. Thus, we implanted the soft GI fiber probe in the ileum of Pyy::ChR2 mice. A schematic illustration depicting optogenetic control of ileal Pyy+ cells with implanted gut fiber in the ileum is shown in
Beyond satiety, the gut signals to the brain to induce motivation and reward. Our gut fiber probes provide an opportunity for testing whether functions of the central nervous system can be directly controlled from the intestine in awake-behaving mice (
Phox2b::ChR2 mice implanted with multifunctional gut fiber probes to the duodenum were subjected to an RTPP behavioral task during which intraluminal vagal stimulation with blue μLEDs (20 Hz, 10 ms pulse width, 0.5 s ON, Is OFF) caused a significant preference to the light-paired chamber compared to their pre-test values (
Multifunctional brain fiber probe (brain fiber probe) fabrication: The multifunctional brain fiber probes used for the experiments disclosed herein were produced by thermal drawing (in one implementation of the process, as shown in
Multifunctional gut fiber probe (gut fiber probe) fabrication: Referring again to
Multifunctional fiber probe fabrication: Fabrication of an implantable brain fiber probe 200 began with drawing a fiber preform 201a into a long (e.g., ˜50 m) fiber 203 as described above and for example as shown in
Connection to microfluidic channel was established through a T-connection at the proximal end of the fiber probe 203 using soft access tubing 233. For this purpose, the microfluidic channel on the fiber probe was first exposed with a sharp razor blade cut and subsequently the fiber probe was threaded into the access tubing 233 through a metallic needle with an inner diameter similar to the fiber size. The T-junction was made water-tight by flowing UV-epoxy at the tubing-polymer junction. Successful microfluidic connection was confirmed by flowing a bolus of DI water. Finally, a 10 μm layer of vapor deposited parylene-C defined the bio-fluid barrier layer. The final fiber probe assembled in this way (shown in
A soft multifunctional gut/GI fiber probe can be made by drawing a preform 301a as described above (in one implementation of the thermal drawing process, as shown in
Fiber probe characterization: For cross-sectional imaging of the fiber probes, samples from different sections of the draw (three each) were cold mounted into epoxy resin and subsequently polished on an automated grinding machine with series of progressively finer sandpapers. The polished epoxy blocks were imaged on a Carl Zeiss inverted microscope. The electrode impedance (n=3 fiber probes) was measured with a precision LCR meter (HP4284A, Agilent Technologies) with a sinusoidal input (10 mV, 20 Hz to 10 kHz). The optical characterization of fiber probe μLEDs (n=3 fiber probes) was performed by powering them with a DC power supply at different voltages and recording the light output with a photodetector (S121C, 400-1100 nm, 500 mW, Thorlabs) attached to a power meter (PM100D, Thorlabs). The I-V response of the μLEDs was measured with a potentiostat in a two-electrode configuration (Solartron).
We characterized the bending stiffness of the fiber probes with a dynamic mechanical analyzer (Q800, TA Instruments). Different samples (n=3 each) of 1.2 cm lengths were mounted in a single cantilever clamp and tested with a frequency sweep (0.1-10 Hz) under controlled displacement (20 μm) at 37° C. The cyclic bending tests (n=3 fiber probes) for soft gut fiber probes was performed with a mechanical testing machine (Z2.5 with testXpert III V1.11, Zwick/Roell) at varying displacements over 104 cycles, while recording the light output from μLEDs at 2.7V after every decade. The diode-based thermal sensors (n=3 fiber probes) were calibrated against a commercial thermocouple by equilibrating the fiber probe and thermocouple on a hot plate at different temperatures and recording the current response using a potentiostat (Solartron) at 2.2 V forward bias.
The microfluidic capability of brain fiber probes (n=3) was evaluated by connecting the probes to an injection system NanoFil syringe, UMP-3, Word Precision Instruments) and flowing a DI water bolus at different injection speeds. The injection output was measured by weight and the injection rate was calculated by dividing the calculated injected volume by the time required to inject it. Identical procedure was employed for microfluidic characterization of gut fiber probes, except the injection of 0.2 ml bolus was performed manually over different times to yield required injection rates commensurate with intragastric infusions.
Optical simulations: Finite-elements simulation via COMSOL Multiphysics were used to calculate the optical field of the tissues. For absorbing-scattering media like biological tissues, the light transport equation was employed, where the light fluence rate at a given location in steady state Φ(r) obeys D∇2Φ(r)−μaϕ(r)=0. D=(μa+μs′)/3 is the diffusion constant, μa is the absorption coefficient of the medium, and μs′ is the reduced scattering coefficient. Table 1 shows the absorption and reduced scattering coefficients of the brain and intestine at different excitation wavelengths.
The brain was modeled as a homogeneous medium with absorption and reduced scattering coefficient specified in Table 1. The dimension of the brain model was set to be large such that the radiative power decays to zero before reaching to the boundary of the brain. To model the power of μLED, an omnidirectional plane source is inserted at the center of the brain. The power of the source is defined to be two times the actual power to account for the emission directivity of the μLED. The intestine is modeled as two coaxial cylinders filled with chyme, with the outer one being the serosoal membrane (r=1.8 mm) and the inner one being the mucosal membrane (r=1.5 mm). The μLED is placed at the center of the coaxial structure. As the chyme does not scatter light, the region of the gut wall is employed for the light transport equation. The μLED emission profile is fitted by a power cosine function. Light emitted from the center of μLED is propagated to the inner surface of the intestine to determine the light fluence rate at the inner walls, which is used as a boundary source to calculate the power distribution in the intestine region.
Thermal simulations: Finite-elements simulation via COMSOL Multiphysics was used to determine the temperature profile of tissues upon excitation of the LEDs. The transient heat transport equation in a biological tissue can be expressed as
where ρ, k, Cp, and u are the density, thermal conductivity, heat capacity, and fluid velocity, respectively. Qbio represents a volumetric bioheat source term that can be further expressed as Qbio=ρbCp,bωb(Tb−T2)+Qmet. Tb,Cp,b,ωp,ρb,Qmet are the arterial blood temperature, specific heat of blood, blood perfusion rate, blood density, and metabolic heat source, respectively. Table 2 lists the parameters used for evaluating Qbio.
In addition to the metabolic heat source, there are two other sources of heat that originate from the μLED. The first heat source is due to the absorbance of optical power in the tissues, and the second heat source is directly from the inefficiency of the μLED. For modeling heat transport in the brain, the first term is introduced through coupling the heat transfer module with the radiation in absorbing-scattering medium module in COMSOL, and the second term is introduced by defining a surface heat source at the μLED surfaces. The temperature profile in the gut was obtained without considering the optical absorption term due to the low optical power at the serosoal membrane and high light transmission through the chyme region. In addition, heat generated by blood perfusion was not considered in the intestine tissue.
Mechanical simulation: Finite element modeling software (Abaqus) was used for the simulation of the bending of the different fibers and the fiber displacement in moving tissue. The element used for the materials in the fiber, such as the cladding polymer, conducting polymer, and metal microwires, was C3D8H with a HEX element shape. The element used for the tissue was C3D10H with a TET element shape. For the bending fiber simulation, the fiber probe was held fixed at one end and was displaced with a fixed distance at the other end. The amount of displacement varied with different curvature radius. For the simulation of implants in the brain tissue, the tissue at its bottom was displaced sideward with a distance of 0.1 mm, while the exposed end of the fiber probe was fixed.
NeuroStack wireless module: A NeuroStack module is composed of a custom printed circuit board (PCB) with an NRF52 microcontroller for BLE communication with the central system (nRF52840 DK development kit) that is connected to a base station computer. A male header pin near the edge of the circular board allows the device to be connected to and disconnected from the implanted multifunctional fiber probe. Two vertical header pins on the base of the board allow for the attachment and removal of the optional modules, including the intensity module. For this study, optional modules for precise intensity control were used across different trials.
To prepare the individual devices and optional modules, components were hand mounted onto the custom PCBs using reflow soldering and software was loaded using J-Link programmers with an Arduino library. The fiber probe μLEDs were driven by either a constant 3.3 V source or a programmable DAC, with a current-limiting series resistor in place to keep the brightness within the desired level. For wireless recording, the transmitted data was collected using a 12-bit ADC and sent over BLE to a central collection point. To improve the bandwidth and reduce packet overhead, the data was batched at the cost of latency in the recordings. The data received was transferred over serial to the MATLAB program or saved for later analysis.
Validation of the device waveforms was done using an oscilloscope to compare measured frequencies and shapes to those specified in the interface. The current consumption patterns were first characterized using a Keithley 100B source meter. A further test of battery life was conducted by running the device with the desired stimulation parameters until the output voltage was below the μLED turn-on voltage. For testing the temperature recording module, the fiber probe was placed on a hotplate with a commercial thermocouple and was left to settle for 30 seconds between each temperature reading. Recordings of the amplifier output voltage and the temperature from the commercial sensor were compared to allow for calibration.
Surgical implantation of multifunctional fiber probes in the brain (brain fiber probes): All animal procedures were approved by the MIT Committee on Animal Care and carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. C57BL/6 mice aged 6-8 weeks (Jackson Laboratory) and transgenic DAT::Ires-Cre mice aged 6-10 weeks were used for the study and all surgeries were conducted under aseptic conditions. Mice were anaesthetized using via intraperitoneal (IP) injection of ketamine/xylazine mixture in saline (in mg/kg bodyweight: ketamine, 100; xylazine, 10), and then positioned in a stereotactic frame (David Kopf Instruments). A skin incision was made to expose the skull. Lambda and bregma points were used to align the skull with respect to the Mouse Brain Atlas. All implantation and injection coordinates were established according to the brain atlas.
A single step injection/implantation was performed in the VTA (VTA, coordinates relative to bregma; −3.2 mm anteroposterior (AP); 0.5 mm mediolateral (ML); −4.4 mm dorsoventral (DV)). Adeno-associated viruses serotype 5 (AAV5) carrying EfIα-DIO-hChR2-mCherry and Efla-DIO-mCherry plasmids were purchased from University of North Carolina Vector Core at concentrations of 2× 1012 particles/mL and 3×1012 particles/ml, respectively. Using a standard microinjection apparatus (NanoFil Syringe and UMP-3 Syringe pump, Word Precision Instruments) 0.8 μl of virus was injected through the microfluidic channels of implanted fiber probes at an infusion rate of 150-300 nl/min. During injections, the fiber probes were raised 0.1 mm to accommodate the virus volume. The stainless-steel ground screw was affixed to the skull on the contralateral hemisphere. Finally, the fiber probe was fixed to the skull with layer of adhesive (C&B Metabond; Parkell) and dental cement (Jet-Set 4, Lang Dental). Following the surgery and recovery, mice were single housed and were maintained at 22° C. and a 12-hour light/dark cycle and provided with food and water ad libitum.
Surgical implantation of multifunctional fiber probes in the gut (gut fiber probes): All animal procedures were approved by the Duke University Institutional Animal Care and Use Committee and carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Adult wild-type, Phox2b::ChR2, Pyy::ChR2, or Cck::ChR2 mice or littermates were anesthetized with isoflurane (1-3% in oxygen). A 1 cm incision was made from the xiphoid process diagonally to left-mid clavicular line. The peritoneal cavity was accessed, and the stomach extra-corporealized for implantation in wild-type, Phox2b::ChR2 and Cck::ChR2 mice. In these mice, the distal end of the fiber probe containing the μLEDs was introduced to the duodenum through the pylorus. To access the pylorus, a purse string suture was made in the gastric antrum, between which a small incision was made in the stomach wall. The distal end of the fiber probe was threaded into the proximal duodenum. The purse string stitch was then tied to secure the fiber probe in the intestine. In Pyy::ChR2 mice, a 1 cm incision was made 3 cm below the xiphoid process to access the cecum. The cecum was extra-corporealized and the distal end of the fiber probe embedded with the μLEDs was introduced into the distal ileum through a purse string suture, as in the duodenal surgeries. The purse string suture was tied to secure the fiber probe in the ileum. In all surgeries, the remaining length of the fiber probe was tunneled to the base of the skull. The peritoneum and overlying skin were sutured closed. The fiber probe exited the tunnel at the base of the skull. The skull was etched with a scalpel blade and a thin layer of Metabond cement (Clear L-powder S399+catalyst; Metabond) was applied. Then, the Metabond layer was etched and the fiber probe was attached using standard dental cement (Stoelting #51458). Mice recovered for at least 5 days during which they were fed wet mash and received appropriate post-operative care. Inclusion criteria at the end of each study were that the fiber probe was appropriately secured in the proximal small intestine and that the μLEDs were operational.
Surgical implantation of dual multifunctional fiber probes in the brain and in the gut (dual brain-gut multifunctional fiber probes, or helical fibers): Wild-type mice (n=6) were implanted with the dual brain-gut multifunctional fiber probes (multisite gut-brain fiber probes). The gut μLED fiber probe was implanted into the duodenum, as described above. Subsequently, the mouse was placed into a stereotaxic frame and the brain fiber probe was directed to the VTA, as described above.
In-vivo electrophysiology: Multifunctional fiber probes were attached to PZ2-32 head stage connected to RZ5D electrophysiology system (Tucker Davis Technologies, TDT). Optogenetic stimulation pulses were delivered with integrated blue or green μLEDs. For all experiments, pulsed stimulation with 5 ms pulse width was used. Stimulation was delivered in 1-s stimulation epochs separated by 4-second rest epochs. Following recording, electrophysiological signal was digitized with 50 kHz sampling frequency and filtered in the frequency range 0.3-5 kHz. Subsequent signals processing and analysis was done with Matlab (Mathworks). Spiking activity was detected using threshold detection with a threshold set at five standard deviations from the mean of the signals, with a downtime of 2 ms to reject double detections. Clustering and classification of spikes were performed by principal component analysis (PCA) and Gaussian mixture model (GMM) clustering (with full and independent covariance matrices). The quality of the clustered data was assessed by calculating the L-ratio and the isolation distance of the classified clusters.
In-vivo impedance spectroscopy: To assess the stability of tungsten microelectrodes in-vivo, we performed electrochemical impedance spectroscopy of tungsten electrode v/s ground screw in VTA implanted BL/6 mice for up to 6 months (n=3 mice) with a portable BioLogic VMP3 potentiostat.
In-vivo intracranial temperature measurements: Wireless intracranial temperature measurements were performed in an open field test. BL/6 mice (n=6) implanted in the VTA with multifunctional fiber probes (pre-calibrated) were coupled to NeuroStack module and allowed to explore an open field arena (30 cm×30 cm) as they received wireless photostimulation (20 Hz, 10 ms pulse width) with implanted blue μLED for 200 seconds. Real-time feed on intracranial temperature was received throughout the session. Anesthesia induced brain hypothermia was quantified by i.p. injection of a mixture of Ketamine-Xylazine (9:1 dilution) at 30 mg/kg and 60 mg/kg dosage in n=3 VTA implanted BL/6 mice. The temperature measurements were performed until the animal gained consciousness and began freely moving in the homecage.
In-vivo gut temperature measurements: Wireless gut temperature measurements were performed in a clean homecage with food and water removed. A wild-type mouse was implanted with a μLED embedded gut fiber probe to the duodenum. Temperature was continually recorded for 10 minutes, with blue light pulsed.
In-vivo gut optofluidic modulation with simultaneous vagal cuff electrophysiology: Whole nerve recordings were performed in Cck::ChR2 mice. A soft multifunctional GI fiber probe with two connected tubes for PBS perfusion and stimulant delivery was surgically inserted through the stomach wall into the duodenum. A perfusion exit incision was made at the ligament of Treitz for the small intestine. To control for volume pressure and to act as a within subject baseline, PBS was constantly perfused through the isolated intestinal region at about 400 μL per minute. Stimulation conditions were applied after recording 2 minutes of baseline activity. During nutrient stimulation conditions, PBS perfusion was continuous and 200 μL of stimulant was perfused over 1 minute using a syringe pump (Fusion 200, Chemyx). The 1-minute infusions of each ligand were separated by at least 6 minutes, or the return to baseline firing rate, whichever came first. Sucrose [300 mM] was used as the nutrient, as it stimulates the vagal firing rate. Blue light (λ=470 nm, 20 Hz, 30.3 mW/mm2, 10 ms pulse width) or green light (2=527 nm, 20 Hz, 45.6 mW/mm2, 10 ms pulse width) was delivered concomitant with the sucrose infusion. Extracellular voltage was recorded. The raw data were analyzed using SpikeTailor, a custom MATLAB software (MathWorks) script. Spikes were detected using a threshold detected based on RMS noise. The firing rate was calculated using a Gaussian kernel smoothing algorithm in 200 ms bins.
Real time place preference assay in brain and gut implanted mice: Behavioral tests were performed by an investigator with knowledge of the identity of the experimental groups versus control groups. Brain. DAT::IRES-Cre mice injected in the VTA in a one-step implantation/injection procedure (AAV5-EF1a-DIO-hChR2-mCherry or AAV5-DIO-mCherry; n=8-10/group) were handled and acclimated to the investigator for 5 mins each prior to the beginning of the behavior. The mice were then acclimated to NeuroStack by connecting the module to the I/O pins of the implanted fiber probe and then allowed to explore their homecage for 15 minutes. On the following day (pre-test day), NeuroStack module carrying mice were allowed to freely explore an unbiased two-compartment chamber (60 cm×30 cm×30 cm) for 30 minutes while being video recorded. The time spent by each animal in both the chambers was calculated with commercial software (Ethovision XT Noldus). Mice that showed >70% preference to a chamber in the baseline explorations were discarded from subsequent analysis.
On the day of the test, the less preferred chamber for each animal was coupled to wireless photostimulation condition by controlling NeuroStack from a base computer. The live video feed from a recording camera provided input on the animal location and the investigator controlled the status of the stimulation condition in real-time. Three different photostimulation conditions were tested using the above procedure: (1) blue stim ON (25 Hz, 10 ms pulse width, Is ON, 2 s OFF) v/s blue stim OFF; (2) Phasic stim (40 Hz, 5 ms pulse width, 0.5 s ON, 4 s OFF) v/s tonic stim (5 Hz, 1 ms pulse width, ON); and (3) blue stim (25 Hz, 10 ms pulse width, Is ON, 2 s OFF) v/s green stim (25 Hz, 10 ms pulse width, Is ON, 2 s OFF).
For gut testing, Phox2b::ChR2 mice and their negative genotype littermates were implanted with the soft GI fiber probe to the duodenum. Mice were acclimated to investigator handling and connection to the NeuroStack module as in the brain experiments. On the day before the test, NeuroStack module was attached the the I/O pins of the implanted fiber probe and mice were allowed to freely explore an unbiased chamber (Techniplast Greenline IVC cage for mice) for 20 minutes. Animal activity was determined by beams crossed in the x and y planes and was collected with a 100 Hz scan rate using the TSE PhenoMaster software. On test day, the less preferred chamber for each mouse was coupled to wireless photostimulation by controlling the wireless module from a base computer. The live activity feed provided input on mouse location in real-time and the investigator controlled the stimulation in real-time. There were three different conditions: (1) The experimental group was Phox2b::ChR2 mice with blue stim ON (20 Hz, 10 ms pulse width) vs OFF; (2) The LED control group was Phox2b::ChR2 mice with green stim ON (20 Hz, 10 ms pulse width) vs OFF; and (3) the genetic control group was negative genotype littermates with blue stim ON (20 Hz, 10 ms pulse width) vs OFF.
Chow intake in mice duodenal implanted with gut fiber probe: Cck::ChR2 mice or negative controls were implanted with the soft GI fiber probes in the duodenum. Mice were acclimated to the investigator handling and connection to the NeuroStack module. Mice were food deprived overnight (18 h) before connection to the NeuroStack module and 30-minutes of light pulses (20 Hz, 10 ms pulse width). After 30-minutes of stimulation, mice were disconnected from NeuroStack and given access to standard show pellets (Purina 5001). Chow intake was measured each hour for 3 hours. Mice had ad libitum access to water for the duration of the food restriction and testing. Each mouse received blue-light and green-light stimulation, randomized per condition. At least 48-h separated each test day.
Ensure intake in mice ileal implanted gut fiber probe: Pyy::ChR2 mice or negative controls were implanted with the soft GI fiber probes in the ileum. Mice were acclimated to experimenter handling and connection to the NeuroStack module. Mice were acclimated to Ensure (30%) solution for 6 hours following surgical recovery and at least 48 hours before the first experimental session. Mice were food deprived overnight (18 h) before connection to the NeuroStack module. Mice received one-hour of light pulses (20 Hz, 10 ms pulse width), which began 10 minutes before access to the Ensure solution. Ensure (30%) was loaded into 5 mL serological pipettes were fashioned as sippers. Mice had access to the solution for 1-h and intake was measured every 5 minutes. Mice did not have access to food or water during the test sessions. Each mouse received blue-light and green-light simulation, randomized per condition. At least 48 hours separated each test day.
Locomotor tests on brain and gut implanted mice: To test whether brain, gut or gut-brain dual implants coupled to NeuroStack impacted locomotion, we evaluated locomotor behavior over 20 minutes. Open field test on naïve (un-operated) and implanted mice carrying NeuroStack were conducted in an open chamber (60 cm×30 cm×30 cm) for brain implantations and in the homecage for gut and gut-brain dual implantations over 20 min. Locomotor activity was recorded as described in the real time place preference assay. The mouse position, distance traveled, and speed, were calculated from the locomotor and/or activity measurements.
Food intake and water intake of gut and gut-brain implanted mice: Animals were housed individually in a custom-built PhenoMaster behavioral phenotyping system (TSE Systems Inc. Chesterfield, MO). The PhenoMaster was programmed (software version 7.1.1) to automatically maintain a light cycle (0300 lights on; 1500 lights off), temperature control (22° C.), and humidity control (50%). Animals were provided with standard mouse chow (Purina 5001) and reverse osmosis water ad libitum. Food hopper and water bottle were attached to weight sensors (TSE) that made automatic measurements every 5 seconds to the nearest 0.01 g. For drinking measurements, a 10-second smoothing interval with a maximum raw analog-to-digital conversion counts difference of 40,000 was permitted. For weight measurements, a 15-second smoothing interval with a 15 g threshold and a maximum raw analog-to-digital conversion counts difference of 1,000,000 was permitted. Intake was measured every 5 seconds. Data were corrected for minor fluctuations by permitting only a monotonically increasing function for both food and water intake: values that represented negative food intake were replaced by the most recent value. For stability of intake measurements, the mean intake and water intake was calculated for two consecutive days for each individual mouse.
Immunohistochemical evaluation of foreign body response in brain: Animals (n=5 BL/6 mice bilaterally implanted in VTA) were anesthetized with isoflurane, injected with fatal plus (100 mg kg-1 IP), and transcardially perfused with 50 mL of ice-cold PBS followed by 50 mL of ice-cold 4% paraformaldehyde (PFA) in PBS. The fiber probe devices were carefully explanted and the brains were removed and fixed in 4% PFA in PBS for 24 h at 4° C., then stored in PBS afterward. Coronal slices (50 μm thickness) were prepared using a vibratome (Leica VT1000S) and a razor blade (Electron Microscopy Sciences, 72002) in ice-cold PBS. The slices were then stored in PBS at 4° C. in the dark until staining. Slices were permeabilized with 0.3% v/v Triton X-100 and blocked with 2.5% donkey serum in PBS for 30 min. Slices were incubated overnight at 4° C. in a solution of 2.5% donkey serum in PBS and a primary antibody (Iba1: Goat anti-Iba1, ab107159 Abcam, 1:500 dilution; GFAP: Goat anti-GFAP, ab53554 Abcam, 1:1000 dilution). Following incubation, slices were washed three times with PBS. The slices were then incubated with secondary antibody (Donkey anti-Goat Alexa Fluor 488, A11055, 1:1000, Thermofischer) for two hours at room temperature on a shaker followed by three more washes with PBS. Slices were then incubated with DAPI (4′6-diamidino-2-phenylindole) (1:50 000) for another 20 minutes and washed three times with PBS. Fluoromount-G (SouthernBiotech) was used for mounting slices onto glass microscope slides. A laser scanning confocal microscope (Fluoview FV1000, Olympus) was used for imaging with 20× objectives, with z-stack images across the slice thickness. A region of interest for imaging the immune response was chosen based on the fiber probe implantation location.
Immunohistochemical evaluation of foreign body response in the small intestine: Phox2b::tdTomato mice were transcardially perfused with PBS for 3 minutes followed by 4% PFA for 3 minutes at a rate of 600 μl/min. Each small intestine was harvested, opened lengthwise, rolled with the proximal end in the center, and post-fixed in 4% PFA for 3 hours. Tissue was then dehydrated in 10% sucrose for 1 hour and 30% sucrose for at least 12 hours. Samples were embedded in OCT (VWR) and stored at −80° C. Tissue was sectioned onto slides at 16 μm using a cryostat. Tissue slides were post-fixed in 10% normal buffered formalin (VWR) for 10 minutes then washed in tris-buffered saline with 0.05% Tween-20 (TBST) (Sigma). Tissue was then washed with TBST, stained with DAPI (1:4000) for 3 minutes, washed in TBST, and mounted using Fluoro-Gel with Tris Buffer (Electron Microscopy Sciences). Imaging was done on a Zeiss 880 Airyscan inverted confocal microscope. Images were adjusted for brightness/contrast using ImageJ (Fiji).
Immunohistochemical evaluation of foreign body response: Wild type mice (n=5 per group) bilaterally implanted in the VTA with brain fiber probes or commercial silica waveguides (300 μm, FT300UMT Thorlabs) were anesthetized with isoflurane, injected intraperitoneally with fatal plus (100 mg kg−1), and transcardially perfused with 50 mL of ice-cold PBS followed by 50 mL of ice-cold 4% paraformaldehyde (PFA) in PBS. The fiber probes/waveguides were carefully explanted and the brains were removed and additionally fixed in 4% PFA in PBS for 24 h at 4° C., then stored in PBS afterward. Coronal slices (50 μm thickness) were prepared using a vibratome (Leica VT1000S) and a razor blade (Electron Microscopy Sciences, 72002) in ice-cold PBS. The slices were then stored in PBS at 4° C. in the dark until staining. Slices were permeabilized with 0.3% v/v Triton X-100 and blocked with 2.5% donkey serum in PBS for 30 min. Slices were incubated overnight at 4° C. in a solution of 2.5% donkey serum in PBS and a primary antibody (Iba1: Goat anti-Iba1, ab107159 Abcam, 1:500 dilution; GFAP: Goat anti-GFAP, ab53554 Abcam, 1:1000 dilution). Following incubation, slices were washed three times with PBS. The slices were then incubated with a secondary antibody (Donkey anti-Goat Alexa Fluor 488, A11055, 1:1000, Thermofischer) for 2 h in room temperature on a shaker followed by additional three washes with PBS. Slices were then incubated with DAPI (4′ 6-diamidino-2-phenylindole) (1:50 000) for another 20 minutes and washed three times with PBS. Fluoromount-G (SouthernBiotech) was used for mounting slices onto glass microscope slides. A laser scanning confocal microscope (Fluoview FV1000, Olympus) was used for imaging with 20× objectives, with z-stack images across the slice thickness. Region of interest was chosen based on the implant location, imaging the immune response in the device surrounding.
Hematoxylin and eosin stain evaluation of foreign body response: Duodenal tissue from wild-type mice naïve (n=4) and implanted (n=4) to the duodenal implant was sliced and evaluated for hematoxylin and cosin (H&E) by the Duke Pathology Histology Lab. The villus height and crypt depths were measured using ImageJ 2 (1.5.3). For each mouse, the villus height and crypt depth were calculated as the average of 10 villi or crypts.
Statistical analysis: OriginPro or JMP Pro 15 software was used to assess the statistical significance of the comparison studies in this work. Power analyses for determining sample sizes of immunohistochemistry and behavior tests were not performed. Instead, the group sizes were chosen based on previous research conducted in the same brain circuit or intestinal region. This enabled direct comparison of our results with the prior work. In the statistical analysis of fiber probe characterization, one-way ANOVA followed by Tukey's post-hoc comparison test was used with thresholds of *P<0.05, **P<0.01, ***P<0.001. For the comparison between two groups in immunohistochemistry analyses, behavior assays and hypothermia effect quantification paired t-test were used, and significance threshold was placed at *P<0.05, **P<0.01, ***P<0.001. For parametric tests, data distribution was assumed to be normal. Shaded areas and error bars in the figures represent standard deviation.
While various inventive embodiments have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and/or structures for performing the function and/or obtaining the results and/or one or more of the advantages described herein, and each of such variations and/or modifications is deemed to be within the scope of the inventive embodiments described herein. More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the inventive teachings is/are used. Those skilled in the art will recognize or be able to ascertain, using no more than routine experimentation, many equivalents to the specific inventive embodiments described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, inventive embodiments may be practiced otherwise than as specifically described and claimed. Inventive embodiments of the present disclosure are directed to each individual feature, system, article, material, kit, and/or method described herein. In addition, any combination of two or more such features, systems, articles, materials, kits, and/or methods, if such features, systems, articles, materials, kits, and/or methods are not mutually inconsistent, is included within the inventive scope of the present disclosure.
Also, various inventive concepts may be embodied as one or more methods, of which an example has been provided. The acts performed as part of the method may be ordered in any suitable way. Accordingly, embodiments may be constructed in which acts are performed in an order different than illustrated, which may include performing some acts simultaneously, even though shown as sequential acts in illustrative embodiments.
All definitions, as defined and used herein, should be understood to control over dictionary definitions, definitions in documents incorporated by reference, and/or ordinary meanings of the defined terms.
The indefinite articles “a” and “an,” as used herein in the specification and in the claims, unless clearly indicated to the contrary, should be understood to mean “at least one.”
The phrase “and/or,” as used herein in the specification and in the claims, should be understood to mean “either or both” of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases. Multiple elements listed with “and/or” should be construed in the same fashion, i.e., “one or more” of the elements so conjoined. Other elements may optionally be present other than the elements specifically identified by the “and/or” clause, whether related or unrelated to those elements specifically identified. Thus, as a non-limiting example, a reference to “A and/or B”, when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A only (optionally including elements other than B); in another embodiment, to B only (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
As used herein in the specification and in the claims, “or” should be understood to have the same meaning as “and/or” as defined above. For example, when separating items in a list, “or” or “and/or” shall be interpreted as being inclusive, i.e., the inclusion of at least one, but also including more than one, of a number or list of elements, and, optionally, additional unlisted items. Only terms clearly indicated to the contrary, such as “only one of” or “exactly one of,” or, when used in the claims, “consisting of,” will refer to the inclusion of exactly one element of a number or list of elements. In general, the term “or” as used herein shall only be interpreted as indicating exclusive alternatives (i.e., “one or the other but not both”) when preceded by terms of exclusivity, such as “either,” “one of,” “only one of,” or “exactly one of.” “Consisting essentially of,” when used in the claims, shall have its ordinary meaning as used in the field of patent law.
As used herein in the specification and in the claims, the phrase “at least one,” in reference to a list of one or more elements, should be understood to mean at least one element selected from any one or more of the elements in the list of elements, but not necessarily including at least one of each and every element specifically listed within the list of elements and not excluding any combinations of elements in the list of elements. This definition also allows that elements may optionally be present other than the elements specifically identified within the list of elements to which the phrase “at least one” refers, whether related or unrelated to those elements specifically identified. Thus, as a non-limiting example, “at least one of A and B” (or, equivalently, “at least one of A or B,” or, equivalently “at least one of A and/or B”) can refer, in one embodiment, to at least one, optionally including more than one, A, with no B present (and optionally including elements other than B); in another embodiment, to at least one, optionally including more than one, B, with no A present (and optionally including elements other than A); in yet another embodiment, to at least one, optionally including more than one, A, and at least one, optionally including more than one, B (and optionally including other elements); etc.
In the claims, as well as in the specification above, all transitional phrases such as “comprising,” “including,” “carrying,” “having,” “containing,” “involving,” “holding,” “composed of,” and the like are to be understood to be open-ended, i.e., to mean including but not limited to. Only the transitional phrases “consisting of” and “consisting essentially of” shall be closed or semi-closed transitional phrases, respectively, as set forth in the United States Patent Office Manual of Patent Examining Procedures, Section 2111.03.
This application claims the priority benefit, under 35 U.S.C. 119 (e), of U.S. Application No. 63/279,860, filed on Nov. 16, 2021, which is incorporated herein by reference in its entirety for all purposes.
This invention was made with Government support under Grant No. DK127757, R01 NS115025, DK103832, MH122402 awarded by the National Institutes of Health, and under Grant No. EEC1028725 awarded by the National Science Foundation. The Government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/079951 | 11/16/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63279860 | Nov 2021 | US |